These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 29027654

  • 1. Pharmacokinetic drug-drug interactions in the intensive care unit - single-centre experience and literature review.
    Łój P, Olender A, Ślęzak W, Krzych ŁJ.
    Anaesthesiol Intensive Ther; 2017; 49(4):259-267. PubMed ID: 29027654
    [Abstract] [Full Text] [Related]

  • 2. Potential drug-drug interactions and nephrotoxicity in hematopoietic stem cell transplant adult recipients during bone marrow transplantation unit stay.
    Sanchez L, Bacle A, Lamy T, Le Corre P.
    Cancer Chemother Pharmacol; 2019 May; 83(5):827-835. PubMed ID: 30758649
    [Abstract] [Full Text] [Related]

  • 3. Potential drug-drug interactions associated with prolonged stays in the intensive care unit: a retrospective cohort study.
    Moura C, Prado N, Acurcio F.
    Clin Drug Investig; 2011 May; 31(5):309-16. PubMed ID: 21344954
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Childhood obesity: Pharmacokinetics considerations for drugs used in the Intensive Care Unit.
    Donoso F A, Ulloa V D, Contreras E D, Arriagada S D.
    Arch Argent Pediatr; 2019 Apr 01; 117(2):e121-e130. PubMed ID: 30869490
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for potential drug-drug interactions in intensive care unit patients.
    Janković SM, Pejčić AV, Milosavljević MN, Opančina VD, Pešić NV, Nedeljković TT, Babić GM.
    J Crit Care; 2018 Feb 01; 43():1-6. PubMed ID: 28822348
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical significance of potential drug-drug interactions in a pediatric intensive care unit: A single-center retrospective study.
    Choi YH, Lee IH, Yang M, Cho YS, Jo YH, Bae HJ, Kim YS, Park JD.
    PLoS One; 2021 Feb 01; 16(2):e0246754. PubMed ID: 33556128
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of potential drug interactions in patients in an intensive care unit of a university hospital in Brazil.
    Reis AM, Cassiani SH.
    Clinics (Sao Paulo); 2011 Feb 01; 66(1):9-15. PubMed ID: 21437429
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Drug-drug interactions in the medical intensive care unit: an assessment of frequency, severity and the medications involved.
    Smithburger PL, Kane-Gill SL, Seybert AL.
    Int J Pharm Pract; 2012 Dec 01; 20(6):402-8. PubMed ID: 23134100
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study.
    Sinnollareddy MG, Roberts JA, Lipman J, Akova M, Bassetti M, De Waele JJ, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Dimopoulos G, DALI Study authors.
    Crit Care; 2015 Feb 04; 19(1):33. PubMed ID: 25888060
    [Abstract] [Full Text] [Related]

  • 15. Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit.
    Girardi A, Galletti S, Raschi E, Koci A, Poluzzi E, Faldella G, De Ponti F.
    Ital J Pediatr; 2017 Apr 17; 43(1):37. PubMed ID: 28412957
    [Abstract] [Full Text] [Related]

  • 16. [Drug-drug Interactions in Intensive Care].
    Drust A.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2020 May 17; 55(5):300-313. PubMed ID: 32434261
    [Abstract] [Full Text] [Related]

  • 17. [Drug interactions. Mechanisms and clinical relevance].
    Klotz U, Beil W, Gleiter C, Drewelow B, Garbe E, Gillessen A, Mutschler E.
    Internist (Berl); 2003 Nov 17; 44(11):1444-9. PubMed ID: 14689079
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of risk factors for adverse drug events in critically ill patients*.
    Kane-Gill SL, Kirisci L, Verrico MM, Rothschild JM.
    Crit Care Med; 2012 Mar 17; 40(3):823-8. PubMed ID: 22036859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.